Pretreatment with bone marrow–derived mesenchymal stromal cell–conditioned media confers pulmonary ischemic tolerance

This publication has 24 references indexed in Scilit:

• Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis
  The Lancet Respiratory Medicine, 2014
• Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2014
• Foxp3+ Treg cells in humoral immunity
  International Immunology, 2013
• Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro
  Stem Cell Research & Therapy, 2013
• Regenerative and immunomodulatory potential of mesenchymal stem cells
  Current Opinion in Pharmacology, 2006
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
  Cytotherapy, 2006
• Impact of Primary Graft Failure on Outcomes Following Lung Transplantation
  Chest, 2005
• Mesenchymal stem cells: clinical applications and biological characterization
  The International Journal of Biochemistry & Cell Biology, 2004
• Ischemia–Reperfusion–induced Lung Injury
  American Journal of Respiratory and Critical Care Medicine, 2003
• Primary Graft Failure Following Lung Transplantation
  Chest, 1998